Nantahala Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-224,962
Closed -$19.6M 162
2025
Q4
$19.6M Sell
224,962
-75,038
-25% -$5.7M 0.65% 33
2025
Q3
$17.2M Buy
+300,000
New +$17.3M 0.6% 41

Other funds holding GMED

Nantahala Capital Management's GMED Position: Q1 2026 in Review

Nantahala Capital Management sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 224,962 shares — an estimated $19.6M sold.

Nantahala Capital Management first reported a position in GMED in Q3 2025 and held it in 2 quarters. The position peaked at $19.6M in Q4 2025. 607 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Nantahala Capital Management reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Nantahala Capital Management sold 224,962 Globus Medical shares in Q1 2026, an estimated $19.6M.
  • Nantahala Capital Management first reported a position in Globus Medical in Q3 2025 and held it in 2 quarters.
  • Nantahala Capital Management's Globus Medical position peaked at $19.6M in Q4 2025.
  • 607 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.